help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaacs, J. T.
Right arrow Articles by Walsh, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isaacs, J. T.
Right arrow Articles by Walsh, P. C.

Journal of Clinical Endocrinology & Metabolism, Vol 56, 139-146, Copyright © 1983 by Endocrine Society

ARTICLES

Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate

JT Isaacs, CB Brendler and PC Walsh

It has been well established that hyperplastic human prostatic tissue is characterized by a 3- to 4-fold elevation in the content of dihydrotestosterone (DHT) compared to that in normal prostatic tissue. However, the exact mechanism responsible for DHT accumulation has not been established. One hypothesis for the abnormal elevation of DHT content in hyperplastic prostatic tissue is that changes occur in the tissue itself which shift the overall balance of androgen metabolism favoring the increased accumulation of DHT. To test this hypothesis, the metabolic activities that produce and remove DHT were determined in a series of normal as well hyperplastic human prostates. The results of these studies demonstrated that in each of the eight separate hyperplastic prostatic tissues assayed, there was a significant increase in 5 alpha-reductase activity producing DHT concomitant with significant decreases in the 3 alpha- and 3 beta-hydroxysteroid oxidoreductase reductase and 17 beta-hydroxysteroid oxidoreductase oxidase activities removing DHT. These specific alterations result in a major shift in the overall balance of androgen metabolism which favors an increase in the net formation of DHT in hyperplastic prostatic tissue. Such a shift in androgen metabolism is, therefore, at least one mechanism for the well documented increase in DHT content found in hyperplastic human prostatic tissue.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
E. C. Pirog and D. C. Collins
Metabolism of Dihydrotestosterone in Human Liver: Importance of 3{alpha}- and 3{beta}-Hydroxysteroid Dehydrogenase
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3217 - 3221.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Matsuura, A. Hara, M. Kato, Y. Deyashiki, Y. Miyabe, S. Ishikura, T. Sugiyama, and Y. Katagiri
Activation of Human Liver 3alpha -Hydroxysteroid Dehydrogenase by Clofibrate Derivatives
J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1096 - 1103.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society